Physician profile
Laurel A Hurst
NPI 1871245910
$2,542.72
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $286 · 2023: $1,804 · 2024: $288 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.30 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $600.41 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $285.10 | 2023-2024 | Rexulti |
| Axsome Therapeutics, INC. | $200.23 | 2022-2023 | Auvelity |
| Lundbeck LLC | $192.15 | 2023 | Rexulti, Abilify Maintena |
| Supernus Pharmaceuticals, INC. | $181.01 | 2023 | Qelbree |
| Idorsia Pharmaceuticals US INC | $174.56 | 2023 | Quviviq |
| Abbvie INC. | $172.41 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $122.26 | 2025 | Cobenfy |
| Alkermes, INC. | $95.13 | 2023 | Lybalvi, Aristada |
| Janssen Pharmaceuticals, INC | $86.44 | 2023 | Spravato |
| Corium, LLC | $84.45 | 2022-2023 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $72.23 | 2023 | Austedo, Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $61.47 | 2022-2023 | Ingrezza |
| Indivior INC. | $38.39 | 2024-2025 | Sublocade |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $35.26 | 2022-2023 | Trintellix |
| Almatica Pharma LLC | $16.23 | 2023 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.